Institutional Investor Sentiment About Novellus Systems Inc (NASDAQ:NVLS) Improved

Sentiment for Novellus Systems Inc (NASDAQ:NVLS)

Novellus Systems Inc (NASDAQ:NVLS) institutional sentiment increased to 0.11 in Q2 2018. Its up 0.02, from 0.09 in 2018Q1. The ratio has improved, as 4 investment professionals started new and increased stock positions, while 35 decreased and sold stakes in Novellus Systems Inc. The investment professionals in our partner’s database now hold: 13.68 million shares, down from 17.39 million shares in 2018Q1. Also, the number of investment professionals holding Novellus Systems Inc in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 33 Reduced: 2 Increased: 2 New Position: 2.

The stock increased 2.13% or $0.05 during the last trading session, reaching $2.4. About 25,377 shares traded or Infinity% up from the average. Nivalis Therapeutics, Inc. (NASDAQ:NVLS) has 0.00% since December 1, 2017 and is . It has underperformed by 15.62% the S&P500.

Thrivent Financial For Lutherans holds 0.05% of its portfolio in Nivalis Therapeutics, Inc. for 3.21 million shares. Bank Of New York Mellon Corp owns 203,000 shares or 0% of their US portfolio. Moreover, Jane Street Group Llc has 0% invested in the company for 300,000 shares. The Massachusetts-based Putnam Investments Llc has invested 0% in the stock. Sei Investments Co, a Pennsylvania-based fund reported 40,000 shares.

More notable recent Nivalis Therapeutics, Inc. (NASDAQ:NVLS) news were published by: Globenewswire.com which released: “Nivalis Therapeutics Announces Appointment of Cynthia Smith to Board of Directors – GlobeNewswire” on November 03, 2016, also Prnewswire.com with their article: “Novellus Introduces VECTOR Excel – A Modular Platform for Advanced Dielectrics That Require Pre- and Post-Processing – PR Newswire” published on March 14, 2011, Seekingalpha.com published: “Intel Outlook Gets Boost in 2011 Capital Expenditures – Seeking Alpha” on January 20, 2011. More interesting news about Nivalis Therapeutics, Inc. (NASDAQ:NVLS) were released by: Seekingalpha.com and their article: “The Most Overbought S&P 500 Stocks And The 50 Best Year To Date – Seeking Alpha” published on January 24, 2012 as well as Seekingalpha.com‘s news article titled: “Ricky Sandler’s Eminence Capital’s Top Stock Picks – Seeking Alpha” with publication date: August 28, 2011.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.